Chronic Kidney Disease as a Coronary Heart Disease Risk Equivalent

[1]  C. Winearls,et al.  Diagnosing chronic kidney disease , 2010, Current opinion in nephrology and hypertension.

[2]  M. Woodward,et al.  Combined role of reduced estimated glomerular filtration rate and microalbuminuria on the prevalence of peripheral arterial disease. , 2009, The American journal of cardiology.

[3]  C. Fox,et al.  Age-related associations of hypertension and diabetes mellitus with chronic kidney disease , 2009, BMC nephrology.

[4]  I. Idris,et al.  Is diabetes a coronary risk equivalent? Systematic review and meta‐analysis , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[5]  Mahboob Rahman,et al.  The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years. , 2008, The American journal of cardiology.

[6]  M. Jardine,et al.  The Relationship between Proteinuria and Coronary Risk: A Systematic Review and Meta-Analysis , 2008, PLoS medicine.

[7]  D. Levy,et al.  Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study). , 2008, The American journal of cardiology.

[8]  Keith C. Norris,et al.  CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  David W. Johnson,et al.  Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials , 2008, BMJ : British Medical Journal.

[10]  J. Coresh,et al.  Prevalence of chronic kidney disease in the United States. , 2007, JAMA.

[11]  D. Levy,et al.  Cross-classification of microalbuminuria and reduced glomerular filtration rate: associations between cardiovascular disease risk factors and clinical outcomes. , 2007, Archives of internal medicine.

[12]  A. Folsom,et al.  Cardiovascular risk among adults with chronic kidney disease, with or without prior myocardial infarction. , 2006, Journal of the American College of Cardiology.

[13]  A. Garg,et al.  Chronic kidney disease and mortality risk: a systematic review. , 2006, Journal of the American Society of Nephrology : JASN.

[14]  S. Grundy.  Diabetes and coronary risk equivalency: what does it mean? , 2006, Diabetes care.

[15]  A. Murray,et al.  Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. , 2005, Journal of the American Society of Nephrology : JASN.

[16]  Neil J Stone,et al.  Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines , 2004, Circulation.

[17]  Deeb N Salem,et al.  Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. , 2004, Journal of the American Society of Nephrology : JASN.

[18]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.

[19]  C. Baigent,et al.  Study of Heart and Renal Protection (SHARP). , 2003, Kidney international. Supplement.

[20]  L. Eberly,et al.  Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience. , 2003, Diabetes care.

[21]  B. Hemmelgarn,et al.  THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Is Chronic Kidney Disease a Cardiovascular Disease Risk Factor? , 2003, Seminars in dialysis.

[22]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[23]  Jixian Wang,et al.  Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies , 2002, BMJ : British Medical Journal.

[24]  Jiang He,et al.  Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. , 2002, Journal of the American Society of Nephrology : JASN.

[25]  D. Levy,et al.  Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. , 1999, Kidney international.

[26]  R. Foley,et al.  Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  M. Laakso,et al.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. , 1998, The New England journal of medicine.

[28]  J. Mckenney,et al.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) , 1993, JAMA.

[29]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[30]  M. Tonelli.  Should CKD be a coronary heart disease risk equivalent? , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[31]  B. Astor,et al.  ORIGINAL INVESTIGATIONS Pathogenesis and Treatment of Kidney Disease The Impact of Reclassifying Moderate CKD as a Coronary Heart Disease Risk Equivalent on the Number of US Adults Recommended Lipid-Lowering Treatment , 2007 .